Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 891782-63-1 | MDL No. : | MFCD08437666 |
Formula : | C10H13N3O4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | MOLNWRVQKCBISZ-UHFFFAOYSA-N |
M.W : | 239.23 | Pubchem ID : | 52903804 |
Synonyms : |
|
Num. heavy atoms : | 17 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.4 |
Num. rotatable bonds : | 5 |
Num. H-bond acceptors : | 6.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 59.24 |
TPSA : | 101.41 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.38 cm/s |
Log Po/w (iLOGP) : | 1.1 |
Log Po/w (XLOGP3) : | 0.54 |
Log Po/w (WLOGP) : | 1.33 |
Log Po/w (MLOGP) : | -0.61 |
Log Po/w (SILICOS-IT) : | 0.1 |
Consensus Log Po/w : | 0.49 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.56 |
Log S (ESOL) : | -1.59 |
Solubility : | 6.08 mg/ml ; 0.0254 mol/l |
Class : | Very soluble |
Log S (Ali) : | -2.24 |
Solubility : | 1.37 mg/ml ; 0.00574 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -1.99 |
Solubility : | 2.48 mg/ml ; 0.0104 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.67 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
[ 1209646-17-2 ]
5-(4-(tert-Butoxycarbonyl)piperazin-1-yl)pyrazine-2-carboxylic acid
Similarity: 0.84
[ 848308-47-4 ]
5-((tert-Butoxycarbonyl)amino)picolinic acid
Similarity: 0.57
[ 1314931-66-2 ]
tert-Butyl oxazol-4-ylcarbamate
Similarity: 0.53
[ 920313-67-3 ]
tert-Butyl (5-aminopyrazin-2-yl)carbamate
Similarity: 0.53
[ 1799412-29-5 ]
tert-Butyl (3-acetylpyrazin-2-yl)carbamate
Similarity: 0.53
[ 40262-53-1 ]
6-(Dimethylamino)pyrazine-2-carboxylic acid
Similarity: 0.68
[ 54013-06-8 ]
Ethyl 5-aminopyrazine-2-carboxylate
Similarity: 0.64
[ 13924-94-2 ]
Methyl 5-aminopyrazine-2-carboxylate
Similarity: 0.64
[ 118853-60-4 ]
Methyl 6-aminopyrazine-2-carboxylate
Similarity: 0.64
[ 61442-38-4 ]
6-Aminopyrazine-2-carboxylic acid
Similarity: 0.62
[ 1209646-17-2 ]
5-(4-(tert-Butoxycarbonyl)piperazin-1-yl)pyrazine-2-carboxylic acid
Similarity: 0.84
[ 40262-53-1 ]
6-(Dimethylamino)pyrazine-2-carboxylic acid
Similarity: 0.68
[ 40262-73-5 ]
6-(4-Morpholinyl)pyrazine-2-carboxylic acid
Similarity: 0.67
[ 61442-38-4 ]
6-Aminopyrazine-2-carboxylic acid
Similarity: 0.62
[ 848308-47-4 ]
5-((tert-Butoxycarbonyl)amino)picolinic acid
Similarity: 0.57
[ 1209646-17-2 ]
5-(4-(tert-Butoxycarbonyl)piperazin-1-yl)pyrazine-2-carboxylic acid
Similarity: 0.84
[ 40262-53-1 ]
6-(Dimethylamino)pyrazine-2-carboxylic acid
Similarity: 0.68
[ 40262-73-5 ]
6-(4-Morpholinyl)pyrazine-2-carboxylic acid
Similarity: 0.67
[ 54013-06-8 ]
Ethyl 5-aminopyrazine-2-carboxylate
Similarity: 0.64
[ 118853-60-4 ]
Methyl 6-aminopyrazine-2-carboxylate
Similarity: 0.64